Midwest Peptide sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are sold for research use only (RUO), are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.
For research purposes only. This compound is not FDA approved. All data presented is from clinical trials for educational reference.

A triple-peptide combination of BPC-157, TB-500, and GHK-Cu targeting complementary angiogenic, cellular migration, and extracellular matrix remodeling pathways in preclinical research. Premium Research Peptide.
Add $35.01 more to save 8% off
Bundle & Save
Discount applies automatically at checkout once your cart subtotal hits the tier.
For In Vitro Research Use Only — Not for Human or Veterinary Use
Intended Use: This product is sold exclusively for qualified laboratory research use. It is not intended for human or animal use of any kind, including medical, nutritional, or cosmetic applications.
⚠️ Legal Disclaimer: Statements on this site have not been evaluated by the FDA. No product or information on this site is intended to diagnose, treat, cure, or prevent any disease. Use is limited to research institutions, laboratories, or licensed researchers operating within lawful regulatory frameworks.
Terms of Sale: By purchasing from Midwest Peptide, you confirm that you are a qualified researcher or buyer with proper knowledge of safe laboratory handling. You accept full responsibility for compliance with all local, state, and federal regulations. All sales are final.
GLOW is a research peptide blend combining BPC-157, TB-500, and GHK-Cu in a single lyophilized vial. The combination is studied in research for tissue remodeling, extracellular matrix dynamics, and angiogenic signaling pathways. Supplied strictly for Research Use Only.
BPC-157 is studied for tissue protection and gastrointestinal barrier research, TB-500 (a thymosin beta-4 fragment) for actin sequestering and cell migration research, and GHK-Cu for extracellular matrix remodeling research. The combination is studied because the three molecules act on complementary pathways in published research models.
GLOW is studied in preclinical research on tissue repair model systems, vascular endothelial signaling, fibroblast migration, and matrix metalloproteinase activity. All cited studies are conducted in rodent or in-vitro systems consistent with RUO classification.
Other research peptides in this category
Research articles and insights related to GLOW

GLOW dermal matrix research covering collagen composition, elastic fibers, hyaluronic acid, matrix metalloproteinase balance, and fibroblast function in skin research. For research use only.
April 24, 2026

GLOW photoaging research covering UV induced skin damage, matrix metalloproteinase modulation, collagen preservation, and antioxidant defense in photoaging models. For research use only.
April 24, 2026

GLOW blend synergy research covering the pharmacological basis for three peptide combinations, mechanism complementarity, and evidence for synergistic effects. For research use only.
April 14, 2026

TB-500 in GLOW research literature review covering actin sequestering activity, cell migration research, angiogenesis effects, systemic distribution, and the thymosin beta-4 research context. For research use only.
April 9, 2026
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
Every batch of GLOW ships with a third-party COA verifying purity by HPLC (>=99%), identity by mass spectrometry for each component, and the per-component mass ratio. The batch-specific COA is published on this product page before purchase.
Lyophilized GLOW is stored at -20C for long-term storage and 2-8C for short-term use within 30 days. Avoid repeated freeze-thaw cycles. Store in original sealed vials, protected from light.
None of the component peptides (BPC-157, TB-500, GHK-Cu) are FDA-approved. The blend supplied here is for laboratory and research use only and is not approved for diagnostic, therapeutic, or human use.
A strategic peptide combination engineered to enhance gh release through synchronized GHRH and ghrelin receptor activation in experimental research models. Premium Research Peptide.